Shopping Cart 0
Cart Subtotal
USD 0

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Nigeria

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 1995

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 3990

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 5985
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Nigeria

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Nigeria". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Nigeria. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Nigeria. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

Scope

The report provides information on the healthcare, regulatory and reimbursement landscape in Nigeria, and includes-

- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

- Profiles and SWOT analyses of the major players in the pharmaceutical market (GlaxoSmithKline, Pfizer, May & Baker, Novartis and Fidson) and profile and SWOT analyses of the major player in the medical device market (Roche Diagnostics)

- Porter's five forces analysis for pharmaceutical and medical devices market of Nigeria

- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices

- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure

- An overview of the opportunities for and challenges to growth in the Nigerian healthcare market.

Reasons to buy

This report will enhance your decision-making capability by allowing you to-

- Develop business strategies by understanding the trends shaping and driving the Nigerian healthcare market

- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future

- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

- Identify, understand, and capitalize on the opportunities and challenges in the Nigerian healthcare market.

READ MORE

Table Of Content

Scope

Table of Contents

Executive Summary

Overview of Pharmaceutical Market

Overview of Medical Device Market

Porter's Five Forces Model

Market Access

Country Healthcare Landscape

Opportunities and Challenges

Appendix


List Of Figure

List of Figures

Figure 1: Pharmaceutical Market, Nigeria, Revenue (USD bn), 2010-2017 6

Figure 2: Medical Device Market, Nigeria, Revenue (USD m), 2013-2017 6

Figure 3: Country Profile, Nigeria, 2018 10

Figure 4: Pharmaceutical Market, Nigeria, Revenue (USD bn), 2010-2017 12

Figure 5: Pharmaceutical Market, Nigeria, Revenue forecast (USD bn), 2018-2022 12

Figure 6: Pharmaceutical Exports (USD m), Nigeria, 2010-2017 13

Figure 7: Top Export Partners, Nigeria, 2017 13

Figure 8: Pharmaceutical Imports (USD m), Nigeria, 2010-2017 14

Figure 9: Top Import Partners, Nigeria, 2017 14

Figure 10: Distribution Channels, Nigeria 15

Figure 11: Pharmaceutical Market, Nigeria, Major Players 18

Figure 12: Medical Device Market, Nigeria, Revenue (USD m), 2013-2017 33

Figure 13: Overview of Public Healthcare System, Nigeria, 2018 45

Figure 14: NHIS Programmes, Nigeria, 2018 48

Figure 15: Out-of-Pocket Expenditure (% of total expenditure on health), Nigeria, 2010-2017 49

Figure 16: Change in Price Trend in Healthcare Sector (%), Nigeria, 2010-2017 49

Figure 17: NAFDAC, Organizational Structure, Nigeria, 2018 51

Figure 18: Market Authorization Procedure, Nigeria, 2018 52

Figure 19: New Medical Approval Process, Nigeria, 2018 53

Figure 20: Patent Approval Process, Nigeria, 2018 56

Figure 21: Trademark Approval Process, Nigeria, 2018 57

Figure 22: Clinical Trial Regulation Process, Nigeria, 2018 58

Figure 23: Labelling and Packaging Regulations, Nigeria, 2018 61

Figure 24: Life Expectancy (years), Nigeria, 2010-2017 64

Figure 25: Immunization Rate (%), Nigeria, 2010-2017 64

Figure 26: Major Causes of Mortality, No. of deaths ('000), Nigeria, 2012 65

Figure 27: Major Causes of Male Mortality, No. of deaths ('000), Nigeria, 2016 65

Figure 28: Major Causes of Female Mortality, No. of deaths ('000), Nigeria, 2016 65

Figure 29: Disability-Adjusted Life Years by Major Disease ('000), Nigeria, 2015 65

Figure 30: Health Care Personnel (per 1,000 population), Nigeria, 2009-2011 66

Figure 31: PM2.5 (?g per m3), Nigeria, 2010-2017 67

Figure 32: CO2 Emissions (k tons), Nigeria, 2010-2017 67

Figure 33: Healthcare Expenditure (% of GDP ), Nigeria, 2010-2017 68

Figure 34: Public-Private Share (%), Nigeria, 2010-2017 68

Figure 35: Trade Associations, Nigeria 69

Figure 36: Opportunities and Challenges, Nigeria 71


List Of Table

List of Tables

Table 1: Market Access, Pricing of Medicines, Nigeria, 2018 50

Table 2: Market Access, Summary of registration processes with timelines, Nigeria, 2018 52

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Nigeria, Pharmaceutical Market, Medical Devices, Drivers and Barriers, Major Players, Regulatory landscape, Reimbursement landscape, Porter Five Forces,Opportunities and Challenges